Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study

Bai, X; Shoushtari, AN; Warner, AB; Si, L; Tang, BX; Cui, CL; Yang, XL; Wei, XT; Quach, HT; Cann, CG; Zhang, MZ; Pallan, L; Harvey, C; Kim, MS; Kasumova, G; Sharova, T; Cohen, JV; Lawrence, DP; Freedman, C; Fadden, RM; Rubin, KM; Frederick, DT; Flaherty, KT; Long, GV; Menzies, AM; Sullivan, RJ; Boland, GM; Johnson, DB; Guo, J

Guo, J (通讯作者)，Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Melanoma & Sarcoma, Minist Educ, Beijing, Peoples R China.

BRITISH JOURNAL OF DERMATOLOGY, 2022; 187 (3): 401

Abstract

Background Programmed cell death receptor-1 (PD-1) monotherapy is a standard treatment for advanced cutaneous melanoma, but its efficacy and toxicity ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索